Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Despite progress, unmet needs in conditions like GI cancer and inflammatory bowel disease signal opportunities for innovation and growth. BOSTON April 15, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets is growing from $86.0 billion in 2023 to $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028." This research study explores the global market for gastrointestinal diagnostics and therapeutics, predicting revenue trends from 2023 to 2028 based on 2022 data. It offers strategic recommendations for stakeholders to navigate this dynamic field, covering product types and regions. With insights into emerging opportunities, it provides valuable guidance for staying competitive in this evolving market. In 2022, bowel anti-inflammatory drugs and gastrointestinal cancer therapies accounted for approximately 81.0% of the total
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at Barclays PLC from $195.00 to $187.00. They now have an "overweight" rating on the stock.MarketBeat
- AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at BMO Capital Markets from $195.00 to $180.00. They now have an "outperform" rating on the stock.MarketBeat
- Why AbbVie Stock Stumbled Today Despite the Earnings Beat [Yahoo! Finance]Yahoo! Finance
- AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View [Yahoo! Finance]Yahoo! Finance
- AbbVie's Q1: Positive Surprise [Seeking Alpha]Seeking Alpha
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 4/26/24 - Form 8-K
- 4/3/24 - Form 8-K
- 4/2/24 - Form 4
- ABBV's page on the SEC website